GADICKE ANSBERT bought AKTS
January 12, 2026 · Form 4 insider transaction
GADICKE ANSBERT bought 1,112,777 shares of Aktis Oncology, Inc. at $18.00 per share, a transaction worth $20.03M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,112,777
Price
$18.00
Total value
$20.03M
InsiderGADICKE ANSBERT
Role10% owner
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after10,260,064
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were purchased as follows: 219,897 by BV 2018, 8,689 by BV 2018(B), 4,284 by AM BV2018, 46,574 by MPM Oncology and 833,333 by MPM Oncology Impact.; The Reporting Persons disclaim beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.; The shares are held as follows: 341,709 by MPM AM, 3,950,528 by BV 2018, 206,964 by BV 2018(B), 77,911 by AM BV2018, 847,080 by MPM Oncology and 4,835,872 by MPM Oncology Impact.